Encapsulation and assessment of therapeutic cargo in engineered exosomes: a systematic review

Zhen Chen,Min Xiong,Jiaqi Tian,Dandan Song,Shuyin Duan,Lin Zhang

DOI: https://doi.org/10.1186/s12951-023-02259-6

IF: 10.2

2024-01-03

Journal of Nanobiotechnology

Abstract:Abstract Exosomes are nanoscale extracellular vesicles secreted by cells and enclosed by a lipid bilayer membrane containing various biologically active cargoes such as proteins, lipids, and nucleic acids. Engineered exosomes generated through genetic modification of parent cells show promise as drug delivery vehicles, and they have been demonstrated to have great therapeutic potential for treating cancer, cardiovascular, neurological, and immune diseases, but systematic knowledge is lacking regarding optimization of drug loading and assessment of delivery efficacy. This review summarizes current approaches for engineering exosomes and evaluating their drug delivery effects, and current techniques for assessing exosome drug loading and release kinetics, cell targeting, biodistribution, pharmacokinetics, and therapeutic outcomes are critically examined. Additionally, this review synthesizes the latest applications of exosome engineering and drug delivery in clinical translation. The knowledge compiled in this review provides a framework for the rational design and rigorous assessment of exosomes as therapeutics. Continued advancement of robust characterization methods and reporting standards will accelerate the development of exosome engineering technologies and pave the way for clinical studies. Graphical Abstract

biotechnology & applied microbiology,nanoscience & nanotechnology

What problem does this paper attempt to address?

The paper attempts to address issues primarily focused on optimizing and evaluating the efficacy of engineered exosomes as drug delivery vehicles. Specifically, the paper focuses on the following aspects:

1. **Optimization of Drug Loading**: The paper explores various current methods for encapsulating therapeutic cargo into engineered exosomes, including endogenous and exogenous loading techniques. Endogenous loading involves using genetic engineering to make donor cells express the desired proteins, nucleic acids, or drug molecules, and then isolating exosomes containing the bioactive cargo from the cell culture supernatant. Exogenous loading, on the other hand, involves loading drugs or bioactive substances into exosomes after isolation through methods such as incubation, electroporation, sonication, freeze-thaw cycles, and extrusion.

2. **Evaluation of Delivery Efficiency**: The paper discusses in detail the methods and techniques for evaluating exosome drug loading and release kinetics, cellular targeting, biodistribution, pharmacokinetics, and therapeutic effects. These evaluations are crucial for ensuring the efficacy and safety of exosomes in clinical applications.

3. **Surface Modification and Targeted Therapy**: The paper also reviews recent advances in the functionalization and targeting strategies of exosome surfaces. By displaying targeting ligands on the surface of engineered exosomes, precise control over exosome delivery can be achieved, allowing them to be specifically delivered to target cells or tissues. This includes the application of different types of targeting molecules such as peptide ligands, antibody fragments, aptamers, and glycoproteins.

4. **Standardization and Clinical Translation**: The paper emphasizes the importance of establishing reliable engineering guidelines and evaluation strategies to facilitate the clinical translation of engineered exosome technology. Currently, the lack of standardized preparation, drug loading, and quantification methods hinders the clinical application of engineered exosomes. Therefore, developing robust characterization methods and reporting standards is key to advancing the field.

In summary, the paper aims to provide a comprehensive framework for the design and evaluation of engineered exosomes to accelerate their clinical application in the treatment of cancer, cardiovascular diseases, neurological disorders, and immune diseases.